ProCE Banner Activity

Addressing Financial Challenges With Use of New Immunotherapies for Relapsed ALL

Clinical Thought
How do you manage the potential financial challenges to prescribing blinatumomab and other novel immunotherapies for your patients who may benefit from these therapies?

Released: May 19, 2016

Expiration: May 18, 2017

No longer available for credit.

Share

Faculty

Jonathan Webster

Jonathan Webster, MD

Fellow
Division of Hematologic Malignancies
Department of Oncology
Johns Hopkins University
Baltimore, Maryland

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational donation from

Amgen, Inc.

Faculty Disclosure

Primary Author

Jonathan Webster, MD

Fellow
Division of Hematologic Malignancies
Department of Oncology
Johns Hopkins University
Baltimore, Maryland

Jonathan Webster, MD, has no real or apparent conflicts of interest to report.